Mavyret side effects are generally mild and last only as long as you’re taking the drug, which is typically 8 to 16 weeks depending on your hepatitis C treatment plan. Once you finish your course, any lingering headaches, fatigue, or nausea should clear up. Most people tolerate the medication well, and the side effects that do occur rarely become severe enough to stop treatment.
The Most Common Side Effects
In clinical trials submitted to the FDA, the three most frequently reported side effects were headache (13% of patients), fatigue (11%), and nausea (8%). These numbers held steady whether patients were on an 8-week, 12-week, or 16-week course, meaning a longer treatment didn’t make the side effects worse or more frequent. Diarrhea appeared in about 6% of patients across several trial groups but wasn’t common enough to make the overall top three.
For context, placebo groups in controlled trials reported adverse events at nearly the same rate. In one double-blind trial, 65% of patients on Mavyret reported at least one side effect compared to 58% of those taking a placebo. That narrow gap suggests many of the symptoms people experience, like headaches and tiredness, overlap with what they’d feel anyway.
How Long Each Side Effect Typically Lasts
There’s no published data pinpointing, say, “headaches peak at week two and resolve by week four.” What clinical experience shows is that mild side effects tend to appear early in treatment and persist at a low level throughout the course. They resolve once the drug clears your system after you take your final dose. Mavyret treatment lasts 8 weeks for most people who are new to hepatitis C therapy, or 12 to 16 weeks for those with cirrhosis or prior treatment experience.
If a side effect like nausea or fatigue is going to happen, you’ll likely notice it within the first few weeks. Some people find these symptoms ease up on their own partway through treatment as their body adjusts, while others experience them at a consistent but manageable level until they finish.
Side Effects in Specific Patient Groups
Certain groups reported slightly different side effect profiles in clinical trials, though nothing dramatically different from the general pattern. People with compensated cirrhosis saw slightly higher rates of fatigue (15%) and headache (14%), plus itching in about 6% of patients. Those with severe kidney impairment, including people on dialysis, reported itching most frequently at 17%, along with fatigue (12%) and nausea (9%).
Post-transplant patients (liver or kidney) had the highest rates of headache (17%) and fatigue (16%), likely reflecting the additional burden of immunosuppressant medications they were already taking. Itching appeared in about 7% of this group. In all these populations, the side effects were the same type and generally the same severity as in the broader patient pool. They resolve on the same timeline: when treatment ends.
Managing Headaches During Treatment
Staying well hydrated and getting enough rest are the two simplest ways to reduce treatment-related headaches. If you need a pain reliever, acetaminophen is the recommended option, but you need to keep the dose low because your liver is already working hard. The safe ceiling during Mavyret treatment is 2,000 mg per day, which means no more than six 325 mg tablets or four 500 mg tablets in 24 hours. Avoid ibuprofen or aspirin unless your provider specifically approves them.
Managing Nausea During Treatment
Nausea responds well to simple dietary changes. Eating smaller, more frequent meals instead of three large ones keeps your stomach from getting overwhelmed. Cold foods tend to trigger less nausea than hot foods because they produce fewer strong aromas. Greasy, spicy, acidic, and very sweet foods are the most common triggers to avoid.
Ginger is a reliable natural option. Ginger tea, ginger ale, or even gingersnaps can settle mild queasiness. If morning nausea is your main problem, keeping crackers or dry toast by your bed and eating a few before getting up can help. Over-the-counter antacids may also provide relief, but check with your pharmacist about interactions before adding anything new.
Serious Side Effects to Watch For
Mavyret carries an FDA boxed warning, the most prominent safety alert, about the risk of hepatitis B reactivation. This applies to anyone who has a current or past hepatitis B infection, even if it appeared to be resolved. When the hepatitis C virus is suppressed by treatment, hepatitis B can flare up, and in rare cases this has led to liver failure and death. Your provider should test you for hepatitis B before prescribing Mavyret and monitor you during and after treatment if there’s any history of infection.
This risk is not a common side effect. It’s a specific safety concern for a defined group of patients: those co-infected with both hepatitis B and C, and especially those also taking immunosuppressant medications. If you’ve been screened and have no hepatitis B markers, this warning doesn’t apply to you.
What to Expect After Your Last Dose
Once you finish your Mavyret course, side effects should stop within days as the drug leaves your body. There are no well-documented long-term side effects that persist after treatment ends. The follow-up visits you’ll have after finishing are focused on confirming the hepatitis C virus is gone (typically checked 12 weeks after your last dose) rather than monitoring for ongoing drug reactions.
If you’re still experiencing fatigue or other symptoms weeks after completing treatment, that’s worth bringing up with your provider. Persistent symptoms are more likely related to the underlying liver condition or another cause than to lingering effects of the medication itself.